Yu Ke
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Bioactive Natural Diterpenoids Research 23
- Cell death mechanisms and regulation 8
- Metabolomics and Mass Spectrometry Studies 6
-
- Synthesis and biological activity 11
- Quinazolinone synthesis and applications 9
- Co-authors
- Hong‐Min Liu (36 shared papers)Andreas Wieland (1 shared paper)Rafi Ahmed (1 shared paper)Ruan Zhang (1 shared paper)Tahseen H. Nasti (1 shared paper)Laurence A. Turka (1 shared paper)Gordon J. Freeman (1 shared paper)Taofeek K. Owonikoko (1 shared paper)
- Journals
- Medicinal Chemistry Research (5 papers)European Journal of Medicinal Chemistry (5 papers)Bioorganic & Medicinal Chemistry (4 papers)European Journal of Pharmacology (3 papers)Phytotherapy Research (3 papers)
- Partner nations
- ChinaUnited StatesNew Zealand
In The Last Decade
Yu Ke
123 papers receiving 2.9k citations
Yu Ke's Hit Papers
Peers
Comparison fields: 5 of 144
- Immunology 600
- Oncology 691
- Molecular Biology 1.2k
- Cancer Research 240
- Pharmacology 133
Countries citing papers authored by Yu Ke
This map shows the geographic impact of Yu Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Ke more than expected).
Fields of papers citing papers by Yu Ke
This network shows the impact of papers produced by Yu Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Ke. The network helps show where Yu Ke may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Ke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 130 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent Hit paper breakdown → | 2017 | 724 |
| 2 | 2020 | 125 | |
| 3 | 2018 | 82 | |
| 4 | 2007 | 77 | |
| 5 | 2021 | 75 | |
| 6 | 2017 | 73 | |
| 7 | 2011 | 72 | |
| 8 | 2017 | 66 | |
| 9 | 2012 | 66 | |
| 10 | 2009 | 65 | |
| 11 | 2020 | 65 | |
| 12 | 2016 | 52 | |
| 13 | 2018 | 50 | |
| 14 | 2018 | 49 | |
| 15 | 2018 | 48 | |
| 16 | 2018 | 48 | |
| 17 | 2017 | 40 | |
| 18 | 2015 | 40 | |
| 19 | 2014 | 38 | |
| 20 | 2010 | 37 |
About Yu Ke
Yu Ke is a scholar working on Molecular Biology, Organic Chemistry, Plant Science, Pharmacology and Pharmacology, having authored 130 papers that have together received 3.0k indexed citations. Recurring topics across this work include Bioactive Natural Diterpenoids Research (23 papers), Synthesis and biological activity (11 papers), Quinazolinone synthesis and applications (9 papers), Plant-based Medicinal Research (9 papers), Cell death mechanisms and regulation (8 papers), Bone Tissue Engineering Materials (6 papers), Polysaccharides and Plant Cell Walls (6 papers) and Metabolomics and Mass Spectrometry Studies (6 papers). The work is most often cited by research in Immunology (600 citations), Oncology (691 citations), Molecular Biology (1.2k citations), Cancer Research (240 citations) and Pharmacology (133 citations). Yu Ke has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Hong‐Min Liu, Andreas Wieland, Rafi Ahmed, Ruan Zhang, Tahseen H. Nasti, Laurence A. Turka, Gordon J. Freeman, Taofeek K. Owonikoko, Shu Yang and Aiping Liu. Their work appears in journals such as Medicinal Chemistry Research, European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, European Journal of Pharmacology and Phytotherapy Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.